GlassScriptPhysician profile
Dustton W Walker
NPI 1285183616
$1,511.61
in general payments reported to CMS, 2019-2025
18 companies · $635 in 2025
The $635 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.44 · 2023: $570 · 2024: $279 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,483.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $404.60 | 2023-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $219.58 | 2023-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $176.34 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Lundbeck LLC | $150.77 | 2023-2025 | Rexulti |
| Corium, LLC | $126.65 | 2024-2025 | Azstarys |
| Vanda Pharmaceuticals INC. | $78.26 | 2023-2024 | Fanapt, Hetlioz |
| Abbvie INC. | $62.87 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.05 | 2023 | Trintellix |
| Si-Bone, INC. | $46.58 | 2021-2023 | |
| Idorsia Pharmaceuticals US INC | $27.95 | 2023 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $24.39 | 2024 | Austedo Xr |
| Averitas Pharma INC. | $24.21 | 2024 | Qutenza |
| Axsome Therapeutics, INC. | $21.01 | 2023 | Auvelity |
| Amgen INC. | $20.94 | 2024 | Evenity, Prolia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.97 | 2025 | Relistor |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18.12 | 2025 | Inceptiv |
| Ironshore Pharmaceuticals INC. | $17.81 | 2023 | Jornay Pm |
| Nevro Corp. | $16.51 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustton Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.